(Q39142521)

9 September 2017

title

Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells (English)

1 reference

9 September 2017

0 references

Miki Kobayashi

1

1 reference

9 September 2017

Satoki Nakamura

2

1 reference

9 September 2017

Kiyoshi Shibata

3

1 reference

9 September 2017

Naohi Sahara

4

1 reference

9 September 2017

Kazuyuki Shigeno

5

1 reference

9 September 2017

Kaori Shinjo

6

1 reference

9 September 2017

Kensuke Naito

7

1 reference

9 September 2017

Kazunori Ohnishi

8

1 reference

9 September 2017

publication date

1 September 2005

1 reference

European Journal of Haematology

9 September 2017

published in

1 reference

9 September 2017

volume

75

1 reference

9 September 2017

issue

3

1 reference

9 September 2017

page(s)

212-220

1 reference

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Epstein-Barr virus in action in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Bcl-2 and Hsp27 act at different levels to suppress programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

The stereoselective pharmacokinetics of etodolac in young and elderly subjects, and after cholecystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

Enhanced clearance of leukemic lymphocytes in B-cell chronic lymphocytic leukemia with etodolac

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00498.X

10.1111/J.1600-0609.2005.00498.X

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference